Stability of novel plasma markers associated with cardiovascular disease: Processing within 36 hours of specimen collection

Clinical Chemistry

Volumn 48, Issue 10, 2002, Pages 1781-1784

  Pai, Jennifer K ^a   Curhan, Gary C ^a   Cannuscio, Carolyn C ^a   Rifai, Nader ^a   Ridker, Paul M ^a   Rimm, Eric B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; LIPOPROTEIN A; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DISEASE MARKER; ENVIRONMENTAL TEMPERATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MEASUREMENT; TIME;

EID: 0036790342     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.10.1781     Document Type: Article

References (24)

1. Colditz GA. The Nurses' Health Study: a cohort of US women followed since 1976. J Am Med Womens Assoc 1995:50:40-4.
2. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999;340:1390-7.
3. Michaud DS, Manson JE, Spiegelman D, Barbieri RL, Sepkovic DW, Bradlow HL, et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1999;8:1059-64.
4. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989;35:2313-6.
5. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engi J Med 2000;342:836-43.
6. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, et al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001;358:971-6.
7. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481-5.
8. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 1999;19:3071-8.
9. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997;95:205-12.
10. Chu NF, Spiegelman D, Rifai N, Hotamisligil GS, Rimm EB. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord 2000;24:1085-92.
11. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:844-8.
12. Srinivasan SR, Berenson GS. Serum apolipoproteins A-I and B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study. Clin Chem 1995;41:159-64.
13. Vaarala O, Manttari M, Manninen V, Tenkanen L, Puurunen M, Aho K, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995;91:23-7.
14. Rosner BA. Fundamentals of biostatistics, 5th ed. Pacific Grove, CA: Duxbury Thomson Learning, 2000:563.
15. Nilsson L, Hedner U, Nilsson IM, Robertson B. Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion 1983;23:377-81.
16. Heil W, Grunewald R, Amend M, Helns M. Influence of time and temperature on coagulation analytes in stored plasma. Clin Chem Lab Med 1998;36:459-62.
17. Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med 1999;130:933-7.
18. Mondoro TH, Shafer BC, Vostal JG. Restoration of in vitro responses in platelets stored in plasma. Am J Clin Pathol 1999;111:693-9.
19. Lozano M, Estebanell E, Cid J, Diaz-Ricart M, Mazzara R, Ordinas A, et al. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage. Transfusion 1999;39:951-9.
20. Simo JM, Camps J, Vilella E, Gomez F, Paul A, Joven J. Instability of lipoprotein(a) in plasma stored at -70°C: effects of concentration, apolipoprotein(a) genotype, and donor cardiovascular disease. Clin Chem 2001;47:1673-8.
21. Evans RW, Sankey SS, Hauth BA, Sutton-Tyrrell K, Kamboh MI, Kuller LH. Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay. Lipids 1996;31:1197-203.
22. Brey RL, Cote SA, McGlasson DL, Triplett DA, Barna LK. Effects of repeated freeze-thaw cycles on anticardiolipin antibody immunoreactivity. Am J Clin Pathol 1994;102:586-8.
23. Eberl T, Amberger A, Herold M, Hengster P, Steurer W, Hochleitner BW, et al. Expression of stress proteins, adhesion molecules, and interleukin-8 in endothelial cells after preservation and reoxygenation. Cryobiology 1999;38:106-18.
24. Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y, et al. Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993-1998. Jpn Circ J 2000;64:303-8.